首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1374824

全球血液氣體和電解質分析儀市場 -2023-2030

Global Blood Gas and Electrolyte Analyzers Market -2023-2030

出版日期: 2023年11月01日 | 出版商:

DataM Intelligence | 英文 186 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

血氣分析儀從注射器中吸出血液並測量 pH 值以及氧氣和二氧化碳的分壓。也計算碳酸氫鹽濃度。這些結果通常可在五分鐘內解釋。

電解質分析儀是一種專門的醫療設備，旨在測量生物樣本（通常是血液或血清）中的電解質濃度。電解質是必需離子，包括鈉（Na+）、鉀（K+）、氯（Cl-）、碳酸氫鹽（HCO3-）和鈣（Ca2+），在人體內的各種生理過程中發揮著至關重要的作用。準確測量這些電解質水平對於診斷和管理各種醫療狀況至關重要。

市場動態：促進因素與限制因素

科技進步的崛起

對於急診和重症監護環境中的患者來說，一個至關重要的因素是他們快速變化的生理狀態，這種狀態可能會迅速惡化，需要立即診斷和臨床決策以改善患者的治療結果。照護端檢測 (POCT) 是重症監護環境中的一項重大進步，旨在提供分散的、以患者為中心的醫療保健。快速取得血液測量結果，尤其是血液氣體和電解質，可以帶來更好的臨床結果。

例如，2023年6月，煙台必安生物科技有限公司的i-Check手持式血氣電解質分析儀採用了微流控和電化學檢測技術。其拋棄式試劑盒包括塑膠基板、多生物感測器陣列、校準袋、樣品注射端口和廢物室。值得注意的是，多生物感測器陣列是透過網版印刷生產的。所使用的印刷油墨材料僅包含碳、銀和絕緣材料，不含任何貴金屬，與其他製造商相比，大大降低了生產成本。

此外，用於治療癌症和糖尿病等慢性疾病的醫療保健支出的增加預計將在預測期內推動市場成長。這一成長表明重症監護病房和急診科患者數量的增加，導致對血液氣體和電解質分析的需求不斷成長。相關組織和政府不斷參與透過鼓勵患者定期接受診斷檢查來減少醫療保健支出的計劃。

市場動態：克制

由於經典血氣分析需要動脈血液樣本，因此在樣本採集過程中出現了許多挑戰。例如，使用特殊的氣密注射器來避免樣本與外部空氣混合。此外，血液樣本在採集後必須立即充分混合，否則會發生沉澱，導致樣本不均勻。

此外，市場上的一些主要限制因素包括缺乏熟練的專業人員、分析儀的成本、報銷問題和複雜的法規。

有關此報告的更多詳細資訊 - 索取樣本

An electrolyte analyzer is a specialized medical device designed to measure the concentration of electrolytes in a biological sample, typically blood or serum. Electrolytes are essential ions, including sodium (Na + ), potassium (K + ), chloride (Cl-), bicarbonate (HCO3-), and calcium (Ca2 + ), that play crucial roles in various physiological processes within the human body. The accurate measurement of these electrolyte levels is vital for diagnosing and managing a wide range of medical conditions.

Market Dynamics: Drivers and Restraints

Rise in technological advancements

A vital factor for patients in emergency and critical care settings is their rapidly changing physiological state, which can deteriorate quickly and necessitate immediate diagnosis and clinical decisions for improving patient outcomes. Point-of-care testing (POCT) is a significant advancement in critical care settings, designed to provide decentralized, patient-centred healthcare. Quick access to blood measurements, especially blood gases, and electrolytes, can lead to better clinical outcomes.

For instance, in June 2023, i-Check handheld blood gas electrolyte analyzer from B&E Biotechnology Co. Ltd. (Yantai, China) adopted microfluidic and electrochemical detection technology. Its single-use cartridge includes a plastic substrate, a multi-biosensor array, a calibrator pouch, a sample injection port, and a waste chamber. Notably, the multi-biosensor array is produced by silk-screen printing. The printing ink materials used comprise only carbon, silver, and insulation, without any noble metal, which significantly lowers the production cost compared to other manufacturers.

Furthermore, increasing healthcare expenditure for the treatment of chronic diseases, such as cancer and diabetes, is expected to drive market growth over the forecast period. This increase indicates a rise in the number of patients in critical care units and emergency departments, which has led to the growing need for blood gas and electrolyte analysis. Pertinent organizations and governments are constantly engaging in programs to reduce healthcare expenditure by encouraging patients to undergo regular diagnostic examinations.

Market Dynamics: Restraint

Since classical blood gas analysis requires an arterial blood sample, many challenges arise during sample collection. For example, special gas-tight syringes are used to avoid adulteration of the sample with outside air. Furthermore, the blood sample must be properly mixed immediately after collection, otherwise, sedimentation will occur, resulting in an inhomogeneous sample.

Also, some of the major restraining factors in the market include the lack of skilled professionals, the cost of the analyzer, reimbursement issues, and complicated regulations.

For more details on this report - Request for Sample

Segment Analysis

The global blood gas and electrolyte analyzers is segmented based on product type, modality, end-user and region.

The blood gas analyzers from the product type segment accounted for approximately 41.2% of the market share

The blood gas analyzers from the product type segment accounted for 41.2% and it is expected to be dominated during the forecast period. Blood gas analyzers are used to measure combinations of pH, blood gas (i.e. pCO2 and pO2), electrolytes, and metabolite parameters from whole blood samples. Blood conservation is an important initiative in every clinical diagnostic lab or critical care facility. Therefore, a highly accurate blood gas analyzer can streamline work processes and reduce errors with minimum maintenance.

For instance, in June 2022, Sysmex America Inc., a leading name in the diagnostics solutions marketplace, received FDA clearance for the addition of a new feature to its N-10 Automated Hematology Analyzer with Blood Bank mode. This is the first automated analyzer to be cleared for residual WBC counting.

Moreover, in April 2021, Siemens Healthiness launched the epoc blood analysis system, It is a handheld, wireless solution with complete blood gas, a basic metabolic panel, and hematocrit and lactate on a single room temperature-stable test card, delivering patient-side results in less than 1 minute. It aids in supporting COVID-19 response efforts, where blood gas testing plays a critical role in managing infected patients.

Geographical Analysis

North America accounted for approximately 38.4% of the market share in 2022

North America is estimated to hold about 38.4% of the total market share throughout the forecast period, owing to the large presence of domestic and international medical device companies from both the developed and emerging markets boost the demand and growth of analyzes in the country. The region is expected to witness high demand for products such as arterial blood gas machines, electrolyte analyzer machines, and blood oxygen analyzers.

For instance, in March 2020, Siemens Healthineers stated that it won FDA clearance for its RapidPoint 500e blood gas analyzer for diagnosing and monitoring people in the intensive care unit, operating room or emergency room.

RapidPoint 500e is designed to generate blood gas, electrolyte, metabolite, CO-oximetry and neonatal bilirubin results that are then used to diagnose and monitor critically ill patients. The analyzer can be used in COVID-19 response efforts, where blood gas testing helps in managing infected patients and monitoring their respiratory distress.

COVID-19 Impact Analysis

The COVID-19 pandemic positively impacted the blood gas and electrolyte analyzers market. As amid the pandemic several surgeries were postponed, and non-emergency hospitalizations were cancelled impacted the market moderately.

However, there was a rise in the hospitalization rate of people suffering from COVID-19. Surging cases of the COVID-19 pandemic have increased demand for blood gas and electrolyte analyzers in hospitals, clinics, point of care centers will positively influence the industry growth.

Competitive Landscape

The major global players in the blood gas and electrolyte analyzers market include: Abbott Point of Care Inc., Siemens Healthcare Private Limited, Cornley Hi-tech Co., LTD, Radiometer Medical ApS, Chengdu Seamaty Technology Co., Ltd, EDAN Instruments, Inc., ERBA Diagnostics Mannheim GmbH, F Hoffman La Roche Ltd, Medica Corporation, i-SENS, Inc and among others.

Key Developments

In September 2021, Sensa Core Medical Instrumentation stated that the availability of its flagship Blood Gas Analyzer ST-200CC blood gas analyzers - Ultra Smart for hospitals, clinics and diagnostics centres through its network in India.
In May 2020, Roche stated the CE mark availability of Roche v-TAC, a new digital diagnostic solution that allows clinicians to obtain results for arterial blood gas values from patients with respiratory or metabolic abnormalities via a simpler, less invasive venous puncture through the use of a digital algorithm.
In January 2020, Siemens Healthineers stated that its latest critical care testing solution, the RAPIDPoint 500e Blood Gas Analyzer, has received clearance from the U.S. Food and Drug Administration. The analyzer generates blood gas, electrolyte, metabolite, CO-oximetry, and neonatal bilirubin results, which are used to diagnose and monitor critically ill patients in the intensive care unit, operating room, or emergency room.

Why Purchase the Report?

To visualize the global blood gas and electrolyte analyzers market segmentation-based product type, modality, end-user and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development
Excel data sheet with numerous data points of blood gas and electrolyte analyzers market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global blood gas and electrolyte analyzers market report would provide approximately 69 tables, 70 figures, and 185 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Modality
3.3. Snippet by End User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Driver
  - 4.1.1.1. Rise in the technology advancements
  - 4.1.1.2. Rise in prevalence of chronic diseases
- 4.1.2. Restraints
  - 4.1.2.1. Challenges associated with sample collection
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Product Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 7.1.2. Market Attractiveness Index, By Product Type
7.2. Blood Gas Analyzer*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Electrolyte Analyzer
7.4. Combined Analyzer
7.5. Others

8. By Modality

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
- 8.1.2. Market Attractiveness Index, By Modality
8.2. Benchtop*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Portable

9. By End User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals *
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Centralized Laboratories
9.4. Point of Care
9.5. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.6.1. U.S.
  - 10.2.6.2. Canada
  - 10.2.6.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.6.1. Germany
  - 10.3.6.2. UK
  - 10.3.6.3. France
  - 10.3.6.4. Italy
  - 10.3.6.5. Spain
  - 10.3.6.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.6.1. Brazil
  - 10.4.6.2. Argentina
  - 10.4.6.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.6.1. China
  - 10.5.6.2. India
  - 10.5.6.3. Japan
  - 10.5.6.4. Australia
  - 10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Abbott Point of Care Inc
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Siemens Healthcare Private Limited
12.3. Cornley Hi-tech Co., LTD
12.4. Radiometer Medical ApS
12.5. Chengdu Seamaty Technology Co., Ltd
12.6. EDAN Instruments, Inc
12.7. ERBA Diagnostics Mannheim GmbH
12.8. F Hoffman La Roche Ltd
12.9. Medica Corporation
12.10. i-SENS, Inc

LIST NOT EXHAUSTIVE